OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 330
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 330
Showing 76-100 of 330 citing articles:
Holistic approaches in systemic lupus erythematosus: do physicians avoid addressing difficult-to-treat but highly relevant symptoms?
Ioannis Parodis, Chris Wincup, Zahi Touma, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005400-e005400
Open Access
Ioannis Parodis, Chris Wincup, Zahi Touma, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005400-e005400
Open Access
Decreased Expression of Aquaporins as a Feature of Tubular Damage in Lupus Nephritis
Melchior Maxime, Marie Van Eycken, Charles Nicaise, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 380-380
Open Access
Melchior Maxime, Marie Van Eycken, Charles Nicaise, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 380-380
Open Access
A focused report on IFN-1 targeted therapies for lupus erythematosus
Ankeet S. Bhatt, Pooja Gupta, Richard Furie, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-9
Closed Access
Ankeet S. Bhatt, Pooja Gupta, Richard Furie, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-9
Closed Access
Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices
Deniz Gezgin Yıldırım, Emine Yılmaz Orulluoğlu, Çişem Yıldız, et al.
Pediatric Rheumatology (2025) Vol. 23, Iss. 1
Open Access
Deniz Gezgin Yıldırım, Emine Yılmaz Orulluoğlu, Çişem Yıldız, et al.
Pediatric Rheumatology (2025) Vol. 23, Iss. 1
Open Access
Knowledge, attitudes, and practices toward biologics among systemic lupus erythematosus patients: a cross-sectional study
Xue Xu, Mengru Du, Peng Lai, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Xue Xu, Mengru Du, Peng Lai, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Comparison of flares in 85 patients with SLE who maintained, discontinued or reduced dose of hydroxychloroquine during a prospective study of ophthalmological screening for retinopathy (PERFOCTAPS Study)
Juliana Monti Maiffrino Dias, Kévin Chevalier, Vivien Vasseur, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001434-e001434
Open Access
Juliana Monti Maiffrino Dias, Kévin Chevalier, Vivien Vasseur, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001434-e001434
Open Access
Long-term prognosis of lupus nephritis: comparison between pediatric, adult, and advanced age onset
Marta Calatroni, Simeone Andrulli, Federico Doti, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Marta Calatroni, Simeone Andrulli, Federico Doti, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi‐omics analysis
Keishi Fujio, Toshiyuki Ushijima, Tatsuki Abe, et al.
Rheumatology & autoimmunity (2025)
Open Access
Keishi Fujio, Toshiyuki Ushijima, Tatsuki Abe, et al.
Rheumatology & autoimmunity (2025)
Open Access
Belimumab patient profile in Spain: evolution during the last decade and future directions
Tarek Carlos Salman-Monte, María J. Cuadrado, María Galindo, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-11
Open Access
Tarek Carlos Salman-Monte, María J. Cuadrado, María Galindo, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-11
Open Access
Long COVID in patients with systemic lupus erythematosus: A case-control study
Chris Ching Lam Cheung, Chi Chiu Mok
Lupus (2025)
Closed Access
Chris Ching Lam Cheung, Chi Chiu Mok
Lupus (2025)
Closed Access
Levels of physical activity in a large international cohort of patients with systemic lupus erythematosus
Terrence W. Mischler, Lou Kawka, Juan Camilo Sarmiento-Monroy, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001443-e001443
Open Access
Terrence W. Mischler, Lou Kawka, Juan Camilo Sarmiento-Monroy, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001443-e001443
Open Access
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Lupus nephritis II: Treatment and monitoring
Chrisanna Dobrowolski, S. M. Lao, Fadi Kharouf, et al.
Advances in clinical chemistry (2025)
Closed Access
Chrisanna Dobrowolski, S. M. Lao, Fadi Kharouf, et al.
Advances in clinical chemistry (2025)
Closed Access
Association between myosteatosis or sarcopenia based on abdominal CT and hypertension in systemic lupus erythematosus patients
Bowen Wang, Liping Zuo, Jinlei Fan, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Bowen Wang, Liping Zuo, Jinlei Fan, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
The Crosstalk Between NETs and the Complement Cascade: An Overview in Nephrological Autoimmune Disease
Xhuliana Kajana, Gianluca Caridi, Maurizio Bruschi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2789-2789
Open Access
Xhuliana Kajana, Gianluca Caridi, Maurizio Bruschi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2789-2789
Open Access
Transitioning from Lupus Low Disease Activity State to remission in systemic lupus erythematosus: real-world evidence
Dai Gao, Lanlan Ji, Xiaohui Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dai Gao, Lanlan Ji, Xiaohui Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus‐Cruces‐Bordeaux Inception Cohort
Guillermo Ruiz‐Irastorza, D. Paredes, Maria Herrero‐Galvan, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 8, pp. 1132-1138
Open Access | Times Cited: 4
Guillermo Ruiz‐Irastorza, D. Paredes, Maria Herrero‐Galvan, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 8, pp. 1132-1138
Open Access | Times Cited: 4
Systemic lupus erythematosus: one year in review 2024
Davide Schilirò, Ettore Silvagni, Benedetta Ciribè, et al.
Clinical and Experimental Rheumatology (2024)
Open Access | Times Cited: 4
Davide Schilirò, Ettore Silvagni, Benedetta Ciribè, et al.
Clinical and Experimental Rheumatology (2024)
Open Access | Times Cited: 4
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations
Anca Askanase, Richard Furie, Maria Dall’Era, et al.
Lupus Science & Medicine (2024) Vol. 11, Iss. 1, pp. e001124-e001124
Open Access | Times Cited: 4
Anca Askanase, Richard Furie, Maria Dall’Era, et al.
Lupus Science & Medicine (2024) Vol. 11, Iss. 1, pp. e001124-e001124
Open Access | Times Cited: 4
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases
Maya H Buch, Ziad Mallat, Marc R. Dweck, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 614-634
Closed Access | Times Cited: 4
Maya H Buch, Ziad Mallat, Marc R. Dweck, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 614-634
Closed Access | Times Cited: 4
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
Lakshmi Prasanna Vaishnavi Kattamuri, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access
Lakshmi Prasanna Vaishnavi Kattamuri, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access
Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
Decimo Silvio Chiarenza, Raul Mancini, Carolina Bigatti, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Decimo Silvio Chiarenza, Raul Mancini, Carolina Bigatti, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm
Giuseppe A. Ramirez, Chiara Cardamone, Sara Lettieri, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Giuseppe A. Ramirez, Chiara Cardamone, Sara Lettieri, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Chloroquine and hydroxychloroquine induced cardiomyopathy: A systematic review of literature
Vanda Devesa Neto, J Fiuza, Inês Pires, et al.
REC CardioClinics (2025)
Closed Access
Vanda Devesa Neto, J Fiuza, Inês Pires, et al.
REC CardioClinics (2025)
Closed Access
A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus
George Βertsias, Anca Askanase, Andrea Doria, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 7, pp. 1837-1849
Open Access | Times Cited: 3
George Βertsias, Anca Askanase, Andrea Doria, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 7, pp. 1837-1849
Open Access | Times Cited: 3
